JT Stratford LLC’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.7M | Sell |
3,814
-98
| -3% | -$43.6K | 0.26% | 86 |
|
|
2025
Q1 | $1.9M | Sell |
3,912
-44
| -1% | -$21.3K | 0.34% | 69 |
|
|
2024
Q4 | $1.59M | Sell |
3,956
-4,942
| -56% | -$1.99M | 0.26% | 88 |
|
|
2024
Q3 | $4.14M | Buy |
8,898
+17
| +0.2% | +$7.91K | 0.71% | 26 |
|
|
2024
Q2 | $4.16M | Buy |
8,881
+211
| +2% | +$98.9K | 0.77% | 25 |
|
|
2024
Q1 | $3.62M | Buy |
8,670
+2,107
| +32% | +$881K | 0.72% | 26 |
|
|
2023
Q4 | $2.67M | Buy |
6,563
+450
| +7% | +$183K | 0.61% | 34 |
|
|
2023
Q3 | $2.13M | Buy |
6,113
+1,407
| +30% | +$489K | 0.55% | 39 |
|
|
2023
Q2 | $1.66M | Buy |
4,706
+3,158
| +204% | +$1.11M | 0.45% | 61 |
|
|
2023
Q1 | $488K | Buy |
1,548
+212
| +16% | +$66.8K | 0.14% | 154 |
|
|
2022
Q4 | $386K | Buy |
1,336
+54
| +4% | +$15.6K | 0.12% | 159 |
|
|
2022
Q3 | $371K | Sell |
1,282
-79
| -6% | -$22.9K | 0.13% | 130 |
|
|
2022
Q2 | $384K | Buy |
+1,361
| New | +$384K | 0.12% | 148 |
|